Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v7-FR
Language English French
Date Updated 2022-03-02 2018-12-14
Drug Identification Number 02251787 02251787
Brand name CIPRO XL CIPRO XL
Common or Proper name Ciprofloxacin Hydrochloride and Ciprofloxacin Extended Release Ciprofloxacin Hydrochloride and Ciprofloxacin Extended Release
Company Name BAYER INC BAYER INC
Ingredients CIPROFLOXACIN CIPROFLOXACIN
Strength(s) 1000MG 1000MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 50's 50's
ATC code J01MA J01MA
ATC description QUINOLONE ANTIBACTERIALS QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-07-30 2018-07-30
Actual start date 2020-04-29
Estimated end date 2019-04-15
Actual end date 2022-03-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Discontinued as of March 1, 2022
Health Canada comments